Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

The objective of this case–matched study was to compare the efficacy and the toxicity of the addition of clarithromycin (Biaxin) to lenalidomide/low-dose dexamethasone (BiRd) vs lenalidomide/low-dose dexamethasone (Rd) for newly diagnosed myeloma. Data from 72 patients treated at the New York Presby...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gay, Francesca, Rajkumar, S. Vincent, Coleman, Morton, Kumar, Shaji, Mark, Tomer, Dispenzieri, Angela, Pearse, Roger, Gertz, Morie A., Leonard, John, Lacy, Martha Q., Cheng-Kiang, Selina, Roy, Vivek, Jayabalan, David S., Lust, John A., Witzig, Thomas E., Fonseca, Rafael, Kyle, Robert A., Greipp, Philip R., Stewart, A. Keith, Niesvizky, Ruben
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3956597/
https://ncbi.nlm.nih.gov/pubmed/20645430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21777
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky